contractor articles (770)
Active Articles:
A50691: Apligraf®A52430: Clinical Trials – Medical Policy Article
A52432: Billing and Coding: Insertion of anterior segment aqueous drainage device, without extraocular reservoir, external approach (0192T 66183)
A52435: Billing and Coding: Osteopathic Manipulative Treatment
A52437: Billing and Coding: Sentinel Lymph Node Biopsy – Medical Policy Article
A52438: Billing and Coding: Tetanus Immunization
A52470: Billing and Coding: Venipuncture Necessitating Physician’s Skill for Specimen Collection – Supplemental Instructions Article
A52527: Self-Administered Drug Exclusion List: and Biologicals Excluded from Coverage - Medical Policy Article
A52535: Process for Determining Self-Administered Drug Exclusions – Medical Policy Article
A52537: Traumeel Injections
A54137: Response to Comments: Intravenous Immune Globulin (IVIG) L35893
A54185: Billing and Coding: MolDX: Afirma™ Assay by Veracyte Update
A54188: Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID®
A54189: Billing and Coding: MolDX: cobas® EGFR Mutation Test Guidelines
A54191: Billing and Coding: MolDX: FDA-Approved BRAF Tests
A54192: Billing and Coding: MolDX: FDA-Approved EGFR Tests
A54194: Billing and Coding: MolDX: MammaPrint
A54195: Billing and Coding: MolDX: Oncotype DX® Breast Cancer Assay
A54196: Billing and Coding: MolDX: Oncotype DX® Colon Cancer Assay Update
A54197: Billing and Coding: MolDX: Progensa® PCA3 Assay Coverage Update
A54199: Billing and Coding: MolDX: Therascreen® EGFR RGQ PCR Kit Guidelines
A54200: Billing and Coding: MolDX: therascreen® KRAS PCR Kit Guidelines
A54242: Billing and Coding: MolDX: 9p21 Genotype Test
A54244: Billing and Coding: MolDX: ApoE Genotype
A54257: Billing and Coding: MolDX: BluePrint® Test
A54269: Billing and Coding: MolDX: HTTLPR Gene Testing
A54270: Billing and Coding: MolDX: IKBKAP Genetic Testing
A54271: Billing and Coding: MolDX: Immunohistochemistry (IHC) Indications for Breast Pathology
A54272: Billing and Coding: MolDX: KIF6 Genotype
A54274: Billing and Coding: MolDX: L1CAM Gene Sequencing Guidelines
A54278: Billing and Coding: MolDX: MECP2 Genetic Testing
A54283: Billing and Coding: MolDX: SULT4A1 Genetic Testing
A54295: Billing and Coding: MolDX: PIK3CA Gene Tests
A54300: Billing and Coding: MolDx: SEPT9 Gene Test
A54327: Billing and Coding: ArgusM II Retinal Prosthesis System
A54584: Response to Comments: Molecular Diagnostic Tests(MDTs) L36021
A54586: Response to Comments: Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II prothrombin, and MTHFR)
A54588: Response to Comments: MoPath: Special Histochemical Stains and Immunohistochemical Stains
A54607: Response to Comments: MolDx: MGMT Promoter Methylation Analysis DL36113
A54616: Response to Comments: Prolaris Prostate Cancer Genomic Assay
A54617: Response to Comments: Molecular RBC Phenotyping
A54685: Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing
A54686: Billing and Coding: MolDX: BCR-ABL
A54688: Billing and Coding: MolDX: FDA-Approved KRAS Tests
A54689: Billing and Coding: Germline testing for use of PARP inhibitors
A54777: Response to Comments: Bone Mass Measurement
A54780: Response to Comments: MolDX: Chromosome 1p/19q Deletion Analysis
A54781: Response to Comments: Minimally-Invasive Surgical (MIS) Fusion of Sacroiliac (SI) Joint
A54790: Response to Comments: MolDX: Breast Cancer Assay: Prosigna
A54791: Response to Comments: Repetitive Transcranial magnetic Stimulation (rTMS) in Adults with Treatment Resistant Major Depression Disorder
A54813: Response to Comments: MolDX: HLA-DQB1 0602 Testing for Narcolepsy
A54814: Response to Comments: MolDX: BRCA1 and BRCA2 Genetic Testing
A54830: Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268)
A54881: Response to Comments: MolDX: HLA-B*15:02 Genetic Testing
A54899: Response to Comments: MolDX Biomarkers in Cardiovascular Risk Assessment
A54901: Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Next Generation Sequencing Testing in Cancer
A54961: Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemakers – Coding and Billing
A54983: Response to Comments: MolDX-CDD: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A54988: Response to Comments: MolDX Biomarkers in Cardiovascular Risk Assessment
A55276: Response to Comments: Wound Application of Cellular and/or Tissue Based products (CTPs), Lower Extremities
A55305: Response to Comments: MolDX- CDD: ProMark Risk
A55306: Response to Comments: MolDX-CDD: Decipher® Prostate Cancer Classifier Assay
A55313: Response to Comments: Proton Beam Therapy
A55315: Billing and Coding: Proton Beam Therapy
A55427: Response to Comments: GlycoMark Testing for Glycemic Control
A55430: Response to Comments: Polysomnography and Other Sleep Studies
A55432: Response to Comments: Nerve Conduction Studies and Electromyography
A55435: Response to Comments: MolDX: HLA-DQB1*06:02
A55436: Response to Comments: MolDX - CDD: Oncotype DX ® Breast Cancer for DCIS (Genomic Health ™)
A55451: Response to Comments: Bladder/Urothelial Tumor
A55452: Response to Comments: MolDX: APC and MUTYH Gene
A55453: Response to Comments: MolDX-CDD: Percepta©
A55561: Response to Comments: MolDX DecisionDX Uveal
A55562: Response to Comments: MolDX: Xpresys Lung
A55564: Response to Comments: MolDX: VitaRisk ™ Pharmacogenetic Test for Dry Age-related Macular Degeneration (AMD)
A55566: Response to Comments: MolDX: Prolaris™ Prostate Cancer Genomic Assay for Men with Favorable Intermediate Risk Disease
A55715: Billing and Coding: Coenzyme Q10 (CoQ10)
A55716: Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML)
A55736: Response to Comments: MolDX: Prometheus IBD sgi Diagnostic Policy
A55835: Billing and Coding: Sacral Nerve Stimulation for Urinary and Fecal Incontinence
A55876: Response to Comments: MolDX: EndoPredict Breast Cancer Gene Expression Test
A56050: Billing and Coding: FDA Approved CLL Companion Diagnostic Test
A56083: Billing and Coding: Rezum® System for Benign Prostatic
A56106: Billing and Coding: MolDX: Microsatellite Instability-High (MSI-H) and Mismatch Repair Deficient (dMMR) Biomarker for Patients with Unresectable or Metastatic Solid Tumors
A56142: Response to Comments: MolDX: Corus® CAD Assay
A56148: Response to Comments: MolDX: Guardant360® Plasma-Based Comprehensive Genomic Profiling in Non-Small Cell Lung Cancer (NSCLC)
A56159: Billing and Coding: Frequency of Hemodialysis
A56161: Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
A56175: Low frequency, non-contact, non-thermal ultrasound (CPT code 97610)
A56177: Response to Comments: MolDX: Cystatin C Measurement
A56190: Response to Comments: MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)
A56239: Response to Comments: Frequency of Hemodialysis DL37575
A56283: Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test
A56289: Billing and Coding: Therapeutic Apheresis for Familial Hypercholesterolemia
A56313: Response to Comments: MolDX: Oncotype DX AR-V7 Nucleus Detect for Men with Metastatic Castrate Resistant Prostate Cancer (MCRPC)
A56345: Billing and Coding: MolDX: Oncotype DX® Genomic Prostate Score
A56354: Response to Comments: MolDX: MDS FISH
A56366: Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test
A56374: Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer
A56424: Billing and Coding: Allergy Immunotherapy
A56425: Billing and Coding: B-type Natriuretic Peptide (BNP) Testing
A56439: Billing and Coding: Blepharoplasty
A56448: Billing and Coding: Breast Imaging Mammography/Breast Echography (Sonography)/Breast MRI/Ductography
A56451: Billing and Coding: Cardiac Computed Tomography (CCT) and Coronary Computed Tomography Angiography (CCTA)
A56452: Billing and Coding: Cardiac Event Detection
A56453: Billing and Coding: Cataract Extraction
A56454: Billing and Coding: Cerumen (Earwax) Removal
A56455: Billing and Coding: Chiropractic Services
A56457: Billing and Coding: Corneal Pachymetry
A56459: Billing and Coding: Debridement Services
A56460: Billing and Coding: Dialysis Access Maintenance
A56461: Billing and Coding: Endoscopy by Capsule
A56462: Billing and Coding: Erythropoiesis Stimulating Agents (ESA)
A56464: Billing and Coding: Flow Cytometry
A56465: Billing and Coding: GlycoMark® Testing for Glycemic Control
A56467: Billing and Coding: Laser Ablation of the Prostate
A56471: Billing and Coding: Bladder/Urothelial Tumor Markers
A56472: Billing and Coding: Botulinum Toxins
A56493: Billing and Coding: Capsule Opacification Following Cataract Surgery: Discission and YAG Laser Capsulotomy
A56494: Billing and Coding: Cardiovascular Nuclear Medicine
A56496: Response to Comments: MolDX DecisionDx-Melanoma
A56500: Billing and Coding: Cardiac Catheterization and Coronary Angiography
A56535: Billing and Coding: Minimally-Invasive Surgical (MIS) Fusion of the Sacroiliac (SI) Joint
A56594: Billing and Coding: Panretinal (Scatter) Laser Photocoagulation
A56596: Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification (NAATs)
A56692: Billing and Coding: Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
A56697: Billing and Coding: Non-Invasive Vascular Studies
A56779: Billing and Coding: Intravenous Immune Globulin
A56798: Billing and Coding: Vitamin D Assay Testing
A56799: Billing and Coding: Visual Fields Testing
A56800: Billing and Coding: Virtual Colonoscopy (CT Colonography)
A56802: Billing and Coding: Urodynamics
A56808: Billing and Coding: Transtelephonic Spirometry
A56809: Billing and Coding: Transesophageal Echocardiography (TEE)
A56811: Billing and Coding: Transcatheter Infusion Therapy
A56816: Billing and Coding: Computerized Corneal Topography
A56818: Billing and Coding: Urine Drug Testing
A56836: Billing and Coding: Mohs Micrographic Surgery
A56881: Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
A56884: Billing and Coding: MolDX: Breast Cancer Index™ (BCI) Gene Expression Test
A56885: Billing and Coding: MolDX: HLA Testing for Transplant Histocompatibility
A56887: Billing and Coding: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
A56926: Billing and Coding: MDS FISH
A56940: Billing and Coding: MolDX: Prometheus IBD sgi Diagnostic Policy
A56973: Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)
A56980: Billing and Coding: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
A56981: Billing and Coding: MolDX: DecisionDx-UM (Uveal Melanoma)
A56982: Billing and Coding: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
A56983: Billing and Coding: MolDX: MGMT Promoter Methylation Analysis
A56985: Billing and Coding: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
A56988: Billing and Coding: Cystatin C Measurement
A56989: Billing and Coding: MolDX: Breast Cancer Assay: Prosigna®
A56997: Billing and Coding: MolDX: EndoPredict Breast Cancer Gene Expression Test
A56998: Billing and Coding: MolDX: NRAS Genetic Testing
A56999: Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A57032: Billing and Coding: MolDX: AlloSure® Donor-Derived Cell-Free DNA Test
A57034: Billing and Coding: ProMark® Risk Score
A57038: Billing and Coding: Surveillance of Implantable or Wearable Cardioverter Defibrillators (ICDs): Office, Hospital, Web, or Non-Web Based
A57039: Billing and Coding: Stretta Procedure
A57040: Billing and Coding: Speech-Language Pathology
A57041: Billing and Coding: Somatosensory Testing
A57043: Billing and Coding: RAST Type Tests
A57044: Billing and Coding: Removal of Benign Skin Lesions
A57047: Billing and Coding: Transcranial Magnetic Stimulation (TMS)
A57049: Billing and Coding: Polysomnography and Other Sleep Studies
A57050: Billing and Coding: Post-Void Residual Urine and/or Bladder Capacity by Ultrasound
A57052: Billing and Coding: Psychiatric Inpatient Hospitalization
A57053: Billing and Coding: Psychiatric Partial Hospitalization Programs
A57054: Billing and Coding: Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians
A57065: Billing and Coding: Outpatient Psychiatry and Psychology Services
A57067: Billing and Coding: Outpatient Physical and Occupational Therapy Services
A57068: Billing and Coding: Ocular Photography - External
A57069: Billing and Coding: Ophthalmic Angiography (Fluorescein and Indocyanine Green)
A57070: Billing and Coding: Ophthalmic Biometry for Intraocular Lens Power Calculation
A57071: Billing and Coding: Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
A57132: Billing and Coding: Bone Mass Measurement
A57141: Billing and Coding: MolDX: Repeat Germline Testing
A57149: Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea
A57155: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
A57160: Billing and Coding: Immune Thrombocytopenia (ITP) Therapy
A57165: Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing
A57193: Billing and Coding: Routine Foot Care and Debridement of Nails
A57282: Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
A57284: Billing and Coding: Nasal Punctum-Nasolacrimal Duct Dilation and Probing with or without Irrigation
A57285: Response to Comments: Micro Invasive Glaucome Surgery (MIGS)
A57305: Billing and Coding: Varicose Veins of the Lower Extremity, Treatment of
A57306: Billing and Coding: Transthoracic Echocardiography (TTE)
A57307: Billing and Coding: Nerve Conduction Studies and Electromyography
A57386: Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment
A57663: Billing and Coding: Nerve Blocks for Peripheral Neuropathy
A57870: Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
A57873: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57876: Response to Comments: MolDX: Next-Generation Sequencing for Solid Tumors
A57877: Response to Comments: MolDX: Next Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57910: Billing and Coding: MolDX: Testing of Multiple Genes
A57915: Billing and Coding: MolDX: Pigmented Lesion Assay
A57916: Response to Comments: MolDX: Pigmented Lesion Assay
A57917: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A57918: Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A57926: Billing and Coding: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
A57929: Response to Comments: Immune Thrombocytopenia (ITP) Therapy
A57930: Response to Comments: Hypoglossal Nerve Stimulation for the Treatment of Obstructive Sleep Apnea
A57994: Billing and Coding: Implantable Automatic Defibrillators
A58038: Billing and Coding: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A58039: Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer
A58040: Response to Comments: MolDX: Repeat Germline Testing
A58061: Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58063: Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
A58065: Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58113: Off-Label Use of Drugs and Biologicals for Anti-Cancer Chemotherapeutic Regimen
A58178: Response to Comments: MolDX: Pharmacogenomics Testing
A58218: Billing and Coding: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58270: Response to Comments: Vitamin D Assay Testing
A58323: Billing and Coding: Magnetic Resonance Guided Focused Ultrasound Surgery System (MRgFUS) for the treatment of neurologic conditions
A58324: Billing and Coding: MolDX: Pharmacogenomics Testing
A58359: Billing and Coding: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
A58362: Billing and Coding: Colon Capsule Endoscopy
A58368: Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A58371: Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A58382: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A58398: Response to Comments: Computed Tomography Cerebral Perfusion Analysis (CTP)
A58434: Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
A58452: Response to Comments: MolDX: Blood Product Molecular Antigen Typing
A58462: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
A58463: Response to Comments: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
A58480: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A58562: Response to Comments: Controlled Substance Monitoring and Drugs of Abuse Testing
A58563: Response to Comments: Magnetic Resonance Guided Focused Ultrasound Surgery System (MRgFUS) for the treatment of neurologic condition
A58582: Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
A58613: Response to Comments: Facet Joint Interventions for Pain Management
A58647: Response to Comments: MolDX: Breast Cancer Index® (BCI) Gene Expression Test
A58677: MolDX: Algorithm definition as a component of a laboratory test
A58687: Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58706: Billing and Coding: Electroretinography (ERG)
A58708: Response to Comments: MolDX: EndoPredict Breast Cancer Gene Expression Test
A58713: Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A58727: Response to Comments: Off-label Use of Rituximab and Rituximab Biosimilars
A58731: Billing and Coding: Epidural Steroid Injections for Pain Management
A58734: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A58735: Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58737: Billing and Coding: Platelet Rich Plasma Injections for Non-Wound Injections
A58743: Response to Comments: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
A58747: Billing and Coding: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
A58817: Billing and Coding: Influenza Diagnostic Tests
A58894: Response to Comments: Platelet Rich Plasma Injections for Non-Wound Injections
A58899: Response to Comments: Epidural Steroid Procedures Injections for Pain Management
A58916: Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer
A58943: Response to Comments: Electroretinography (ERG)
A58998: Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers
A59006: Off-Label Use of Chemotherapeutic Drugs and Biologicals for Non-Cancer Indications
A59007: Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
A59051: Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
A59063: Response to Comments: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A59066: Billing and Coding: Prostate Cancer Detection with IsoPSA™
A59084: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A59112: Response to Comments: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A59126: Pegfilgrastim (Fulphila; Neulasta; Neulasta Onpro; Nyvepria; Udenyca; Ziextenzo) J2506
A59132: Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease
A59154: Billing and Coding: Sacroiliac Joint Injections and Procedures
A59215: Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
A59242: Response to Comments: Prostate Cancer Detection with IsoPSA®
A59253: Response to Comments: Transcranial Magnetic Stimulation (TMS)
A59287: Response to Comments: Transtelephonic Spirometry
A59289: Response to Comments: Allogeneic Hematopoietic Cell Transplantation (HCT) for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
A59292: Billing and Coding: Lab: Immunohistochemistry (IHC) Indications for Breast Pathology
A59299: Billing and Coding: Cosmetic and Reconstructive Surgery
A59301: Response to Comments: Sacroiliac Joint Injections and Procedures
A59318: Billing and Coding: Positron Emission Tomography (PET) Scan for Inflammation and Infection
A59344: Response to Comments: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
A59355: Response to Comments: Positron Emission Tomography (PET) for Inflammation and Infection
A59356: Response to Comments: Cosmetic and Reconstructive Surgery
A59357: Response to Comments: Transthoracic Echocardiography (TTE)
A59374: Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A59382: Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
A59412: Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
A59423: Billing and Coding: Urinary Biomarkers for Chronic Pain Management
A59437: Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A59472: Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
A59474: Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
A59480: Billing and Coding: Trigger Point Injections (TPI)
A59482: Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
A59496: Response to Comments: Urine Drug Testing
A59503: Response to Comments: Urinary Biomarkers for Chronic Pain Management
A59519: Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59527: Response to Comments: Fluid Jet System in the Treatment of Benign Prostatic Hyperplasia (BPH)
A59529: Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59564: Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A59608: Billing and Coding: Cervical Fusion
A59646: Billing and Coding: MolDX: Proteomics Testing
A59647: Response to Comments: Trigger Point Injections (TPI)
A59698: MolDX: Defining panel services in MolDX
A59716: Billing and Coding: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
A59735: Response to Comments: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
A59737: Response to Comments: Facet Joint Interventions for Pain Management
A59738: Response to Comments: Cervical Fusion
A59792: MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic services
A59822: Response to Comments: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
A59850: Response to Comments: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
A59858: Response to Comments: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
A59909: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A59910: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS)
A59928: Response to Comments: Artificial Intelligence Enabled CT Based Quantitative Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
A59941: Response to Comments: Skin Substitute Grafts/Cellular and Tissue-Based Products for the Treatment of Diabetic Foot Ulcers and Venous Leg Ulcers
Retired Articles:
A50740: Category III CPT® Code CoverageA50743: Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy – Supplemental Instructions Article
A50745: Denosumab (Prolia ™, Xgeva ™)
A50751: Immunohistochemistry – Supplemental Instructions Article
A50755: Insertion of anterior segment aqueous drainage device, without extraocular reservoir, external approach (0192T)
A50830: Ocular Photography – External – Supplemental Instructions Article
A50837: Outpatient Psychiatry and Psychology Services - Supplemental Instructions Article
A50840: Panretinal (Scatter) Laser Photocoagulation – Supplemental Instructions Article
A50842: Polysomnography and Sleep Studies – Supplemental Instructions Article
A50843: Psychological Services Coverage under the Incident to Provision for Physicians and Non-physicians - Supplemental Instructions Article
A50844: Capsaicin 8% patch (Qutenza®)
A50846: Sentinel Lymph Node Biopsy – Medical Policy Article
A50849: Swallow Evaluation and Dysphagia Treatment – Supplemental Instructions Article
A50851: Transcatheter Infusion Therapy – Supplemental Instructions Article
A50852: Venipuncture Necessitating Physician’s Skill for Specimen Collection – Supplemental Instructions Article
A50854: Visual Fields Testing - Supplemental Instructions Article
A50860: Endoscopy by Capsule – Supplemental Instructions Article
A50876: Laser Ablation of the Prostate – Supplemental Instructions Article
A51369: Osteopathic Manipulative Treatment
A52375: Category III CPT® Code Coverage
A52377: Erythropoiesis Stimulating Agents (ESA) – Supplemental Instructions Article
A52382: Colonoscopy/Sigmoidoscopy/Proctosigmoidoscopy – Supplemental Instructions Article
A52397: Ophthalmic Biometry for Intraocular Lens Power Calculation – Supplemental Instructions Article
A52400: Outpatient Physical and Occupational Therapy Services Supplemental Instructions Article
A52403: Outpatient Psychiatry and Psychology Services - Supplemental Instructions Article
A52413: Psychiatric Partial Hospitalization Programs – Supplemental Instructions Article
A52422: Billing and Coding: Autologous Cellular Immunotherapy Treatment of Metastatic Prostate Cancer (Sipuleucel-T;Provenge)-Q2043
A52424: Denosumab (Prolia ™, Xgeva ™)
A52425: Drugs and Biologicals, Coverage of, for Label and Off-Label Uses - Supplemental Instructions Article
A52427: Iron Sucrose, Iron Dextran and Ferumoxytol, (Intravenous Iron Therapy)
A52428: Pamidronate Disodium for Injection (e.g., Aredia®)
A52429: Sodium Ferric Gluconate, (Intravenous Iron Therapy)
A52530: Billing and Coding: Capsaicin 8% patch (Qutenza®)-J7336
A52531: Fluocinolone acetonide intravitreal implant
A52533: Thyrotropin Alfa (Thyrogen®)
A53191: MoPath: Afirma™ Assay by Veracyte Update
A53192: MoPath: AlloMap Billing and Coding Guidelines Update
A53194: MoPath: bioTheranostics Cancer TYPE ID® Update
A53195: MoPath: cobas® 4800 BRAF V600 Test Billing/Coding Guidelines
A53197: MoPath: Corus® CAD Test Coding and Billing Guidelines
A53198: MoPath: HERmark® Assay by Monogram Update
A53199: MoPath: MammaPrint Billing and Coding Guidelines Update
A53200: MoPath: Oncotype DX® Breast Cancer Assay Billing and Coding Guidelines
A53201: MoPath: Oncotype DX® Colon Cancer Coding and Billing Guidelines
A53205: MoPath: Vectra™ DA Coding and Billing Guidelines
A53206: MoPath: Vysis® Kit by Abbott Coding and Billing Guidelines
A53248: MoPath: ResponseDX Tissue of Origin® Test
A53612: MoPath: ThxID™ BRAF V600/K Test Coding and Billing Guidelines
A53718: Approved Gene Testing
A53799: Approved Gene Testing
A54187: Billing and Coding: MolDX: Avise PG Assay
A54190: MolDX: Corus® CAD Test Coding and Billing Guidelines
A54201: Billing and Coding: MolDX: Vectra™ DA
A54240: Bladder Tumor Marker FISH Billing and Coding Guidelines Update
A54243: Billing and Coding: MolDX: CHD7 Gene Analysis Guidelines
A54258: Billing and Coding: MolDX: CFTR Gene Analysis
A54262: Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests
A54263: Billing and Coding: MolDX: FANCC Genetic Testing
A54267: Billing and Coding: MolDX: HBB Gene Tests
A54268: Billing and Coding: MolDX: HEXA Gene Analysis
A54273: Billing and Coding: MolDX: know error®
A54277: Billing and Coding: MolDX: MCOLN1 Genetic Testing Guidelines
A54282: Billing and Coding: MolDX: TERC Gene Tests
A54290: Billing and Coding: MolDX: myPap™
A54292: Billing and Coding: MolDX: OncoCee™
A54676: MolDX: Vysis® Kit by Abbott Coding and Billing Guidelines
A54848: Drug Administration Coding
A54878: Billing and Coding: MolDX: CDH1 Genetic Testing
A55851: Billing and Coding: MolDX: ThermoFisher Oncomine Dx Target Test For Non-Small Cell Lung Cancer
A56307: Billing and Coding: MolDX: ClonoSEQ® Assay for Assessment of Minimal Residual Disease (MRD) in Patients with Specific Lymphoid Malignancies
A56469: Billing and Coding: Lumbar Epidural Steroid Injections (ESI)
A56470: Billing and Coding: Magnetic Resonance Image Guided High Intensity Focused Ultrasound (MRgFUS) for Essential Tremor
A56543: Billing and Coding: Durvalumab (Imfinzi)-J9173
A56577: Billing and Coding: Docetaxel; Taxotere -J9171
A56579: Billing and Coding: Paclitaxel; Taxol -J9267
A56604: Billing and Coding: Bevacizumab: Avastin-J9035
A56627: Billing and Coding: Beleodaq (Belinostat)-J9032
A56628: Billing and Coding: Fluocinolone Acetonide Intravitreal Implant -J7311
A56629: Billing and Coding: Iron Sucrose, Iron Dextran and Ferumoxytol, (Intravenous Iron Therapy)-J1439, J1750, J1756, Q0138, Q0139
A56698: Billing and Coding: Arsenic Trioxide (Trisenox) - J9017
A56699: Billing and Coding: Asparaginase (E.coli)(Elspar) - J9019
A56700: Billing and Coding: Asparaginase Erwinia Chrysanthemi (Erwinaze) - J9020
A56701: Billing and Coding: Ado-Trastuzumab Emtansine -J9354
A56806: Billing and Coding: Pamidronate Disodium; Aredia -J2430
A56810: Billing and Coding: Panitumumab; Vectibix -J9303
A56829: Billing and Coding: Neulasta® (pegfilgrastim) -J2505,Q5108,Q5111
A56830: Billing and Coding: Atezolizumab (Tecentriq) - J9022
A56831: Billing and Coding: Aldesleukin; Proleukin, Interleukin II (IL-2) -J9015
A56832: Billing and Coding: Alemtuzumzb (Campath) -J0202
A56834: Billing and Coding: Azacitidine (Vidaza) -J9025
A56835: Billing and Coding: Vedolizumab (Entyvio) -J3380
A56864: Billing and Coding: MolDX: CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing
A56882: Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome
A56886: Billing and Coding: Blinatumomab (Blincyto) -J9039
A56889: Billing and Coding: Bendamustine hydrochloride; Bendeka -J9034
A56890: Billing and Coding: Bleomycin Sulfate (Blenoxane) -J9040
A56891: Billing and Coding: Bortezomib (Velcade) -J9041
A56892: Billing and Coding: Brentuximab Vedotin (Adectris) -J9042
A56893: Billing and Coding: Cabazitaxel; Jevtana -J9043
A56894: Billing and Coding: Carfilzomib (Kyprolis) -J9047
A56895: Billing and Coding: Eculizumab; Soliris -J1300
A56939: Billing and Coding: Carboplatin -J9045
A56950: Billing and Coding: MolDX: Corus® CAD Assay
A56971: Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing
A56972: Billing and Coding: MolDX: Percepta® Bronchial Genomic Classifier
A56974: Billing and Coding: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels
A56986: Billing and Coding: MolDX: Molecular RBC Phenotyping
A56990: Billing and Coding: MolDX: DecisionDx-Melanoma
A56992: Billing and Coding: MolDX: Decipher® Prostate Cancer Classifier Assay
A57230: Billing and Coding: Category III CPT® Codes
A57288: Billing and Coding: MolDX: Circulating Tumor Cell Marker Assays
A57303: Billing and Coding: MolDX: Prolaris™ Prostate Cancer Genomic Assay
A57321: Billing and Coding: Rituximab -J9311, J9312, J9999, Q5115
A57446: Billing and Coding: MolDX: TruGraf Blood Gene Expression Test